
Sign up to save your podcasts
Or


Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
By John Simboli5
77 ratings
Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.

3,069 Listeners

1,952 Listeners

1,099 Listeners

2,357 Listeners

948 Listeners

791 Listeners

124 Listeners

321 Listeners

6,066 Listeners

94 Listeners

10,017 Listeners

522 Listeners

152 Listeners

248 Listeners

185 Listeners